George Cardoza Biography and Net Worth

EVP – Chief Financial Officer of SOPHiA GENETICS

George Cardoza, M.B.A.  joined the SOPHiA GENETICS leadership team as Chief Financial Officer in November 2024. Prior to joining SOPHiA GENETICS, he was the Chief Financial Officer and Head of Service Delivery for Biocartis. He joined Biocartis from Accuragen, where he was the Chief Executive Officer.

Before leading Accuragen, George spent over twelve years with NeoGenomics in various leadership roles including Chief Financial Officer, President of Pharma Services and Chief Operating Officer. He also spent more than fourteen years with Quest Diagnostics in various roles including the Controller of the Central Region.

George holds a Bachelor of Science degree from Syracuse University with a dual major in Finance and Accounting, and a Masters in Business Administration from Michigan State University.

What is George Cardoza's net worth?: The estimated net worth of George Cardoza is at least $1.55 million as of April 8th, 2026. Mr. Cardoza owns 291,458 shares of SOPHiA GENETICS stock worth more than $1,553,471 as of May 1st. This net worth evaluation does not reflect any other investments that Mr. Cardoza may own. Learn More about George Cardoza's net worth.
How do I contact George Cardoza?: The corporate mailing address for Mr. Cardoza and other SOPHiA GENETICS executives is , , . SOPHiA GENETICS can also be reached via phone at 41-21-694-1060. Learn More on George Cardoza's contact information.
Has George Cardoza been buying or selling shares of SOPHiA GENETICS?: During the last quarter, George Cardoza has sold $30,801.99 in SOPHiA GENETICS stock. Most recently, George Cardoza sold 1,403 shares of the business's stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $4.85, for a transaction totalling $6,804.55. Following the completion of the sale, the chief financial officer now directly owns 291,458 shares of the company's stock, valued at $1,413,571.30. Learn More on George Cardoza's trading history.
Who are SOPHiA GENETICS's active insiders?: SOPHiA GENETICS's insider roster includes George Cardoza (EVP – Chief Financial Officer), Philippe Menu (Insider), Kevin Puylaert (SVP, Chief Sales Officer), and Abhimanyu Verma (EVP, Chief Technology Officer). Learn More on SOPHiA GENETICS's active insiders.
Are insiders buying or selling shares of SOPHiA GENETICS?: In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company. Learn More about insider trades at SOPHiA GENETICS.
Information on this page was last updated on 4/27/2026.

George Cardoza Insider Trading History at SOPHiA GENETICS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2026	Sell	1,403	$4.85	$6,804.55	291,458
4/7/2026	Sell	2,413	$4.88	$11,775.44	292,861
4/6/2026	Sell	2,520	$4.85	$12,222.00	295,274
3/19/2026	Sell	774	$4.79	$3,707.46	184,858

George Cardoza Buying and Selling Activity at SOPHiA GENETICS

SOPHiA GENETICS Company Overview

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Today's Range

Now: $5.32

$5.23

$5.37

50 Day Range

MA: $4.81

$4.10

$5.28

2 Week Range

Now: $5.32

$2.59

$5.70

Volume

51,479 shs

Average Volume

169,220 shs

Market Capitalization

$364.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04